Clinical Trials Logo

Breast Cancer clinical trials

View clinical trials related to Breast Cancer.

Filter by:

NCT ID: NCT02340858 Completed - Breast Cancer Clinical Trials

Percutaneous Irreversible Electroportion for Unresectable Breast Cancer

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

This trial is studying how well Irreversible Electroportion (IRE) therapy works in treating patients with breast cancer. IRE kills tumor cells by Electrical impulses creating nano-pore on the cell membrane and inducing target cell death.This may be an effective treatment for patients with unresectable breast cancer.

NCT ID: NCT02338115 Completed - Breast Cancer Clinical Trials

Defining an Exposure Target for Weekly Paclitaxel Infusion in Breast Cancer Patients

Start date: May 2014
Phase: N/A
Study type: Observational

The purpose of this prospective observational study is to understand the relationship between paclitaxel exposure and development of peripheral neuropathy during treatment.

NCT ID: NCT02337582 Completed - Breast Cancer Clinical Trials

Colombian Screening Mammography Project

Start date: January 2007
Phase: N/A
Study type: Interventional

A cluster randomized controlled trial was performed in Bogotá, Colombia between 2007-2008 to evaluate the effects of an opportunistic (hospital-based) screening program (intervention) vs. usual care (control) in which 26 clinics were randomized to an intervention (N=13) or control arm (N=13). At intervention clinics general practitioners were instructed to perform clinical breast examination (CBE) on all women aged 50-69 years attending clinics for non-breast health related issues, and to refer them for mammographic screening. Physicians from control clinics were not specifically instructed to perform breast-screening or refer women for mammography, but could do so if they thought it appropriate ('usual care'). Women were followed for 2 years post-randomization.

NCT ID: NCT02336750 Completed - Breast Cancer Clinical Trials

Adding Mirtazapine to Dexamethasone and Aprepitant for Delayed Emesis

Start date: December 2014
Phase: Phase 3
Study type: Interventional

Comparing Dexamethasone, Aprepitant and Mirtazapine With Dexamethasone and Aprepitant in Delayed Emesis Control and Appetite Improvement

NCT ID: NCT02336737 Completed - Breast Cancer Clinical Trials

SentiMag® Intraoperative Comparison in Breast Cancer

SentiMagIC
Start date: January 2015
Phase: N/A
Study type: Interventional

The purpose of this pivotal study is to provide prospective evidence that the SentiMag®/SiennaXP® is safe and non-inferior to the current standard of care for lymph node localization in patients with breast cancer as part of a sentinel lymph node biopsy (SLNB) procedure and to summarize measures of product safety and performance.

NCT ID: NCT02335957 Completed - Breast Cancer Clinical Trials

OPTimizing Irradiation Through Molecular Assessment of Lymph Node (OPTIMAL)

OPTIMAL
Start date: April 2015
Phase: N/A
Study type: Interventional

The main purpose of this study is to show the non-inferiority of the incidental irradiation, as compared to intentional irradiation of the axillary nodes, in terms of 5-years disease-free survival (DFS) of early stage breast cancer patients with limited affectation of sentinel node assessed by OSNA (250 to 15,000 copies/uL), treated with breast-conservative surgery without axillary lymphadenectomy.

NCT ID: NCT02335671 Completed - Clinical trials for Breast Cancer Stage II

Evaluating Mass Spectrometry And Intraoperative MRI In The Advanced Multimodality Image Guided Operating Suite (Amigo) In Breast-Conserving Therapy

Start date: February 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the use of intra-operative Magnetic Resonance Imaging (MRI) and Mass Spectrometry (MS) during breast conserving surgery, and to determine if these tests are capable of accurately predicting the presence or absence of breast tumor in surgical specimens at the margins.

NCT ID: NCT02334085 Completed - Breast Cancer Clinical Trials

The Health of Women Study

HOW
Start date: August 2009
Phase:
Study type: Observational

The HOW Study is a first-of-its-kind international online study for women and men with and without a history of breast cancer. The investigators will collect information about your health, your job, your diet, and your family history, among other topics that can help us get a better understanding of breast cancer and its potential causes. Periodically, the investigators will send you questionnaires about anything and everything. All you have to do is fill them out online. It's that simple. This is a partnership and the investigators need you for the long haul. The more questionnaires you fill out, the more information the investigators will have that can help us have a better understanding of why women get breast cancer.

NCT ID: NCT02332876 Completed - Clinical trials for Cognitive Dysfunction

Physical Activity and Neuropsychological Outcomes in a Cancer Population

Start date: August 2014
Phase: N/A
Study type: Interventional

Many cancer survivors experience treatment-related impairments in mental abilities such as memory, attention, and concentration (known as cognition). Research indicates that physical activity can improve cognition in healthy adults; however, little is known about whether physical activity can improve cognition among cancer survivors. This study will test whether a physical activity intervention results in improvements in cognition among breast cancer survivors, which may lead to interventions to improve cognition.

NCT ID: NCT02328313 Completed - Breast Cancer Clinical Trials

Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older

Start date: October 2014
Phase: N/A
Study type: Interventional

To determine if exercise will affect the increase in p16 expression that is associated with both chemotherapy administration and advancing age.